✦ LIBER ✦

Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status

✍ Scribed by A. Akdaş; L. Türkeri; T. Akoĝlu

Book ID: 110552658
Publisher: Springer Netherlands
Year: 1990
Tongue: English
Weight: 284 KB
Volume: 22
Category: Article
ISSN: 0301-1623
DOI: 10.1007/bf02549736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of tumour necrosis factor a

Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients

✍ Marco Maltoni; Laura Fabbri; Oriana Nanni; Emanuela Scarpi; Laura Pezzi; Emanuel 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 535 KB

Serum levels of tumour necrosis factor-α

Serum levels of tumour necrosis factor-α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome

✍ R. STASI; M. BRUNETTI; S. BUSSA; M. CONFORTI; L. S. MARTIN; M. LA PRESA; M. BIAN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Serum levels of interleukin-1b, tumour n

Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity

✍ L. Altomonte; A. Zoli; L. Mirone; P. Scolieri; M. Magaró 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 377 KB

Serum levels of interleukin-8, tumor nec

Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity

✍ Mahmoud F. ABDEL-HAMID; Dalia G. ALY; Nevine E. SAAD; Hanaa M. EMAM; Dina F. AYO 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB

Serum and ascitic fluid levels of interl

Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer

✍ Mark M. Moradi; Linda F. Carson; Leo B. Twiggs; J. Brice Weinberg; A. F. Haney; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Correlation of serum levels of CA-549 to

Correlation of serum levels of CA-549 to disease status in posttreatment serial samples from breast cancer patients

✍ Kurtis R. Bray; Pramod K. Gaur 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

CA-549 is a high molecular weight, circulating marker for breast cancer defined by its reactivity to monoclonal antibody BC4E 549. CA-549 has recently been shown to be elevated in the sera of 50% of advanced breast cancer patients (n = 80), as compared to < 2.0% of benign breast disease patients (n